Table 3 Characteristics of all published human-to-human cohorts with a clear clinical outcome
From: Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans
Accesstion number | Disease | Success definition | Number of FMTs | 16S vs WGS | Reference |
|---|---|---|---|---|---|
PRJEB46777 | UC | Simple clinical colitis activity index scores (\(\le 2\)) | 43 | WGS | [55] |
PRJEB46779 | Antibiotics resistance (AR) | Decline in the number of symptoms | 33 | WGS | [55] |
PRJNA672867 | Melanoma | Response to PD-1 therapy | 26 | WGS | [56] |
PRJEB36140 | IBS | Decline in the number of symptoms | 30 | WGS | [57] |
CRA004875 | IBD | Mayo score | 103 | 16S | [37] |